These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9006889)
21. Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes. Kimura K; Sasaki N; Asano A; Mizukami J; Kayahashi S; Kawada T; Fushiki T; Morimatsu M; Yoshida T; Saito M Horm Metab Res; 2000 Mar; 32(3):91-6. PubMed ID: 10786926 [TBL] [Abstract][Full Text] [Related]
22. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773 [TBL] [Abstract][Full Text] [Related]
23. A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. Pei G; Samama P; Lohse M; Wang M; Codina J; Lefkowitz RJ Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2699-702. PubMed ID: 7908440 [TBL] [Abstract][Full Text] [Related]
24. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. Ghanouni P; Steenhuis JJ; Farrens DL; Kobilka BK Proc Natl Acad Sci U S A; 2001 May; 98(11):5997-6002. PubMed ID: 11353823 [TBL] [Abstract][Full Text] [Related]
25. Altered activity of palmitoylation-deficient and isoprenylated forms of the G protein-coupled receptor kinase GRK6. Loudon RP; Benovic JL J Biol Chem; 1997 Oct; 272(43):27422-7. PubMed ID: 9341194 [TBL] [Abstract][Full Text] [Related]
26. Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor. Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P J Recept Signal Transduct Res; 1999; 19(1-4):293-300. PubMed ID: 10071765 [TBL] [Abstract][Full Text] [Related]
27. Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors. Pak MD; Fishman PH J Recept Signal Transduct Res; 1996; 16(1-2):1-23. PubMed ID: 8771528 [TBL] [Abstract][Full Text] [Related]
28. Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the beta(2)-adrenergic receptor. Hannawacker A; Krasel C; Lohse MJ Mol Pharmacol; 2002 Dec; 62(6):1431-7. PubMed ID: 12435811 [TBL] [Abstract][Full Text] [Related]
29. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. Ghanouni P; Gryczynski Z; Steenhuis JJ; Lee TW; Farrens DL; Lakowicz JR; Kobilka BK J Biol Chem; 2001 Jul; 276(27):24433-6. PubMed ID: 11320077 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of inverse agonists in cells overexpressing a constitutively active beta2-adrenoceptor and type II adenylyl cyclase. Stevens PA; Milligan G Br J Pharmacol; 1998 Jan; 123(2):335-43. PubMed ID: 9489623 [TBL] [Abstract][Full Text] [Related]
31. Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice. Samama P; Bond RA; Rockman HA; Milano CA; Lefkowitz RJ Proc Natl Acad Sci U S A; 1997 Jan; 94(1):137-41. PubMed ID: 8990174 [TBL] [Abstract][Full Text] [Related]
32. Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations. Seifert R; Gether U; Wenzel-Seifert K; Kobilka BK Mol Pharmacol; 1999 Aug; 56(2):348-58. PubMed ID: 10419554 [TBL] [Abstract][Full Text] [Related]
33. Modeling of sequestration and down regulation in cells containing beta2-adrenergic receptors. Barak LS; Caron MG J Recept Signal Transduct Res; 1995; 15(1-4):677-90. PubMed ID: 8903972 [TBL] [Abstract][Full Text] [Related]
34. FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells. Nakanishi J; Takarada T; Yunoki S; Kikuchi Y; Maeda M Biochem Biophys Res Commun; 2006 May; 343(4):1191-6. PubMed ID: 16580633 [TBL] [Abstract][Full Text] [Related]
35. Agonist-induced conformational changes in the beta2 adrenergic receptor. Kobilka BK J Pept Res; 2002 Dec; 60(6):317-21. PubMed ID: 12464109 [No Abstract] [Full Text] [Related]
36. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation. Rubenstein LA; Zauhar RJ; Lanzara RG J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446 [TBL] [Abstract][Full Text] [Related]
37. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; PiƱeyro G Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574 [TBL] [Abstract][Full Text] [Related]
38. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. Ballesteros JA; Jensen AD; Liapakis G; Rasmussen SG; Shi L; Gether U; Javitch JA J Biol Chem; 2001 Aug; 276(31):29171-7. PubMed ID: 11375997 [TBL] [Abstract][Full Text] [Related]
39. Reconstitution of beta2-adrenoceptor-GTP-binding-protein interaction in Sf9 cells--high coupling efficiency in a beta2-adrenoceptor-G(s alpha) fusion protein. Seifert R; Lee TW; Lam VT; Kobilka BK Eur J Biochem; 1998 Jul; 255(2):369-82. PubMed ID: 9716378 [TBL] [Abstract][Full Text] [Related]
40. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery. Huber T; Menon S; Sakmar TP Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]